Navigation Links
C. Erec Stebbins awarded prestigious EUREKA grant
Date:9/3/2008

C. Erec Stebbins, associate professor at The Rockefeller University, has been awarded an inaugural EUREKA grant from the National Institutes of Health for a project aimed at exploiting a bacteria-based "nanosyringe" as a means of delivering proteins into specific cells for therapeutic purposes. The award, which provides $200,000 a year for three years, was announced by the NIH September 3.

The EUREKA program Exceptional, Unconventional Research Enabling Knowledge Acceleration was established last year to help researchers test novel hypotheses or approach major methodological challenges in projects generally considered too risky for traditional funding vehicles. It is led by the National Institute of General Medical Sciences (NIGMS) with support from the National Institute of Neurological Disorders and Stroke, the National Institute of Mental Health and the National Institute on Drug Abuse. Grant applications were reviewed last fall on several criteria including significance of the problem to be solved, innovation in solving it, logic of the experimental plan and investigator's research history. Unlike conventional grants, however, the EUREKA program does not emphasize the likelihood of a project to produce marketable results. The program awarded a total $42.2 million to 38 scientists.

Stebbins, head of Rockefeller University's Laboratory of Structural Microbiology, studies pathogen-host interactions. In his EUREKA-funded project, Stebbins is examining a molecular tool evolved by pathogenic bacteria that harnesses host energy reserves and precisely delivers toxins into healthy host cells. Stebbins aims to reverse-engineer such a "nanosyringe" for therapeutic use injecting into diseased cells functional versions of proteins that the disease has rendered nonfunctional or proteins that inhibit the action of other, malfunctioning proteins. Clinical applications of the tool include restoring tumor-suppressing proteins or pro-apoptotic polypeptides into cancer cells, injecting enzymes mutated by inherited diseases and introducing transcription inhibitors to shut down genes whose expression might lead to disease.

Stebbins, who earned a Ph.D. in biochemistry and structural biology from Cornell University in 1999 and did postdoctoral research at Yale University School of Medicine, joined Rockefeller University as assistant professor and head of laboratory in 2001, becoming associate professor in 2006. He is the recipient of the American Society of Microbiology's ICAAC Young Investigator Award, among other honors.


'/>"/>

Contact: Joseph Bonner
bonnerj@rockefeller.edu
212-327-8998
Rockefeller University
Source:Eurekalert

Related biology news :

1. 12 McGill researchers awarded Canada Research Chairs
2. Anthony S. Fauci awarded Lasker Award for Public Service
3. ETH Zurich professor Ari Helenius awarded Benoist Prize
4. Nanobiosym awarded $2 million DTRA contract
5. Mustafa alAbsi Ph.D. and national team awarded major NIH grant
6. Parus Interactive Awarded Patent for Speech-Activated Remote System Management
7. $2.7 million awarded for metastatic colon cancer research
8. UCR researchers awarded nearly $1.7M to develop improved cowpea varieties
9. BIO-key(R) and Tiger IT Awarded a Follow-on Contract for Nationwide Voter / Citizen Registration in Bangladesh
10. University awarded £5M to investigate how cells communicate
11. Manomet Center awarded major NFWF grant to foster shorebird conservation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... WARSAW, Poland , Nov. 30, 2016 Not many of us ... most crucial aspects of recovery so we need to do it well. Inadequate sleep ... heart problems, high blood pressure, stroke, diabetes, and even cancer. Maybe now ... a Christmas present that could help them to manage their sleep quality? ... ...
(Date:11/29/2016)... VILNIUS, Lithuania , Nov. 29, 2016 ... high-precision biometric identification and object recognition technologies, ... kit (SDK) for fingerprint recognition solutions that ... extract a fingerprint template using less than ... used in compact devices that have limited ...
(Date:11/24/2016)... Cercacor today introduced Ember TM Sport ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion ... in approximately 30 seconds. Smaller than a smartphone, using ... to key data about their bodies to help monitor ... Hemoglobin carries oxygen to muscles. When hemoglobin ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  Biotheranostics today announced that ... of the Breast Cancer Index (BCI) in identifying ... are most at-risk for disease recurrence and might ... from three studies advancing the understanding of the ... tumor biology and inform decisions related to patient ...
(Date:12/8/2016)... ... December 08, 2016 , ... Opal Kelly, a leading ... interconnect using USB or PCI Express, announced the FOMD-ACV-A4, the company's first FPGA-on-Module ... small, thin, SODIMM-style module that fits a standard 204-pin SODIMM socket for low-cost ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... data bioInformatics portal. In response to client demand KbioBox developed a sophisticated “3 ... biodesign program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016  Soligenix, ... late-stage biopharmaceutical company focused on developing and commercializing ... an unmet medical need, announced today the long-term ... with SGX942 (dusquetide), a first-in-class Innate Defense Regulator ... in head and neck cancer patients undergoing chemoradiation ...
Breaking Biology Technology: